Author(s)
Brian Chun-Fai Chan, MSc, Research Associate1, Brigette Hales, MSc, Project Coordinator1, Neil Shear, MD, FRCPC, Professor of Medicine, Pharmacology2, Vincent Ho, MD, FRCPC, Professor3, Charles Lynde, MD, FRCPC, Dermatologist4, Yves Poulin, MD, FRCPC, Associate Clinical Professor5, Nicole Mittmann, PhD, Director, HOPE Research Centre11HOPE Research Centre, Toronto, ON, Canada; 2 University of Toronto, Toronto, ON, Canada; 3 University of British Columbia, Vancouver, BC, Canada; 4 Lynde Dermatology, Markham, ON, Canada; 5 Laval University and Centre Dermatologique du Quebec metropolitain, Quebec City, QC, Canada
Objective: To determine the lost productivity of Canadian patients with moderate to severe psoriasis. Methods: Seventy-nine consecutive Canadian dermatology patients were interviewed and completed the Work Productivity and Activity Impairment Questionnaire. The inclusion criteria were diagnosis with moderate to severe psoriasis by the treating dermatologist; 19 year of age or older and currently receiving treatment for psoriasis with either a biologic or alternative therapy such as phototherapy, systemic or topical treatments. Patient interviews and data collection occurred between September 21st, 2005 and November 8th, 2005. Results: Eighty-one percent of patients reported working full-time. On average, 2.6 hours (± 6.8)(about 6% of total work hours) were lost from work per week due to psoriasis-related events. When asked how much psoriasis affected their productivity while working, individuals on average reported approximately 20% impairment in productivity due to psoriasis. Twenty-six percent of the patients indicated psoriasis was the reason for altering their job type, description, or work responsibilities. Thirty-four percent of patients believed that their condition affected their choice of career or ability to find a job. Assuming patients were not paid during their absenteeism, absence from work resulted in lost mean patient wages of CDN$2580.97 per person per year. With an estimated 330,000 Canadians suffering from moderate to severe psoriasis, total lost wages due to moderate to severe psoriasis may cost up to approximately CDN$852 million for all moderate to severe psoriasis patients in Canada. Conclusion: The results of this study indicate that moderate to severe psoriasis may have a substantial impact on the work productivity of patients with this disease. Further studies on lost productivity as well as societal impact of moderate to severe psoriasis are needed.
Conference/Value in Health Info
2008-05, ISPOR 2008, Toronto, Ontario, Canada
Value in Health, Vol. 11, No. 3 (May/June 2008)
Code
PSS43
Topic
Economic Evaluation
Topic Subcategory
Work & Home Productivity - Indirect Costs
Disease
Sensory System Disorders